Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2010

View Archived Issues

Electroporation can increase the efficacy of DNA vaccination for prostate cancer

MMP12 polymorphism linked to asthma and chronic obstructive pulmonary disease

Novel ER alpha and beta ligands discovered by Czech scientists

InNexus Biotechnology develops new skin-permeating psoriasis product

FDA grants fast track designation to Sopherion Therapeutics' Myocet in breast cancer

Miraculins and Inverness to collaborate on diagnostic test for pre-eclampsia

Reata and Kyowa Hakko Kirin sign licensing agreement for CKD drug bardoxolone

FDA grants marketing approval to Hi-Tech Pharmacal's Tropazone dermatitis treatment

Pfizer and Debiopharm to initiate phase III trial of tremelimumab in stage IV melanoma

Amira develops solid-dose formulations of FLAP inhibitors

FDA approves Chugai's monoclonal antibody Actemra for moderate to severe RA

Sanofi and KaloBios sign agreement for Humaneered antibody for P. aeruginosa

FDA grants orphan drug designation to Clavis's CP-4126 for pancreatic cancer

Boston Scientific granted Japanese marketing approval for Promus coronary stent system

Delay in FDA review of MannKind's NDA for Afrezza

Study determines pharmacokinetics of HCV candidate ABT-333 in infected patients

Hepatitis C treatment SPC-3649 to enter phase II investigation this year

In vitro data clarify mechanism of action of HCV candidate ATI-0810

AstraZeneca claims fumarate salts of ErbB kinase inhibitors for cancer therapy

Budesonide derivatives presented by Auspex Pharmaceuticals

Celgene describes novel thioxoisoidoline compounds for the treatment of cancer

GSK discloses novel prostanoid EP4 receptor agonists for pain, bone disorders

TetraLogic commences phase I TL-32711 trial in solid tumors or lymphoma

First patient dosed in phase III PLX-4032 trial in metastatic melanoma

Funxional Therapeutics completes phase I FX-125L program

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...